A microfluidic-based cardiovascular diagnostic test system providing lab-level accuracy for point-of-care testing. Designed for quick cardiovascular assessment using the mLabs® platform technology.
Manufactured by
Micropoint Bioscience, Inc.
Santa Clara, CA, United States
Micropoint Biotechnologies Co., Ltd, founded in 2007, has been committing to providing medical professionals and patients with rapid point-of-care diagnostics and self-testing products and solutions that can enhance the quality of health care while increasing patient quality of life. We now have developed 100+ distribution partners all over the world.Based on microfluidic (Lab-on-a-chip) technology, we have strong expertise in cardiovascular disease diagnostics and assessment. We provide high-quality tests for the POC diagnosis of coagulation, diabetes, fertility, infections, and other diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Quidel China Ltd.
China · 1 relevant product
Roche Pharma
Switzerland · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 1 relevant product
37 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 48 closest product alternatives
Quidel China Ltd. · China
The Quidel Cardiovascular Detection System is a diagnostic platform designed for rapid and accurate cardiovascular biomarker testing in laboratory and point-of-care settings. This system delivers real-time results to support clinical decision-making for cardiac risk assessment and patient management.
Roche Pharma · Switzerland
Diagnostic tests and solutions for cardiovascular disease and metabolic disorder assessment.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular diagnostic test kits that guide personalized medication for cardiovascular and cerebrovascular diseases. These kits utilize advanced PCR technology platforms to analyze patient genetic profiles.
45 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products